product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-MEK1 (Ser298) Antibody
catalog :
9128
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat, dog
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 1
Reference
Patel R, Forinash K, Pireddu R, Sun Y, Sun N, Martin M, et al. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res. 2012;72:5025-34 pubmed publisher
product information
SKU :
9128S
Product-Name :
Phospho-MEK1 (Ser298) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R, Mk, (Dg)
Applications :
Western blot
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
45
Host :
Rabbit
Target :
MEK1 (Ser298) phosphate
Primary-Protein :
MEK1
Alt-Names :
Dual specificity mitogen-activated protein kinase kinase 1,ERK activator kinase 1,MAP kinase kinase 1,MAP2K1,MAPK/ERK kinase 1,MAPKK 1,MAPKK1,MEK 1,MEK1,MKK1,MP2K1,PRKMK1,mitogen-activated protein kinase kinase 1,protein kinase, mitogen-activated, kinase 1 (MAP kinase kinase 1)
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.